| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
13,137 | 14,087 | 16,188 | 18,775 | 15,182 | 15,208 | 10,168 | 9,140 | 7,546 |
General and administrative | ||||||||
5,917 | 4,884 | 5,930 | 6,181 | 5,433 | 5,597 | 7,144 | 3,210 | 2,670 |
Total operating expenses | ||||||||
19,054 | 18,971 | 22,118 | 24,956 | 20,615 | 20,805 | 17,312 | 12,350 | 10,216 |
Loss from operations | ||||||||
-19,054 | -18,971 | -22,118 | -24,956 | -20,615 | -20,805 | -17,312 | -12,350 | -10,216 |
Other (expense) income: | ||||||||
Interest income | ||||||||
193 | 273 | 429 | 584 | 407 | 402 | 375 | 271 | 70 |
Interest expense | ||||||||
688 | 201 | 258 | 260 | 258 | 260 | 243 | 253 | 249 |
Change in fair value of warrant liability | ||||||||
- | 0 | 0 | 0 | -252 | 513 | 56 | -1 | 350 |
Other expense | ||||||||
2 | 33 | 14 | 7 | 5 | 54 | 170 | 17 | 15 |
Total other (expense) income, net | ||||||||
-497 | -541 | 157 | 317 | 396 | -425 | -94 | 2 | -544 |
Net loss | ||||||||
-19,551 | -19,481 | -21,961 | -24,639 | -20,219 | -21,186 | -17,406 | -12,348 | -10,760 |
Net loss per share —basic and diluted | ||||||||
-0.64 | -0.23 | -0.74 | -0.83 | -1.56 | -3.87 | -3.38 | -2.57 | -2.27 |
Weighted-average common shares outstanding —basic and diluted | ||||||||
30,333 | 30,325 | 29,856 | 29,667 | 12,963 | 5,730 | 5,146 | 4,811 | 4,743 |